Sept. 2, 2025—Qiagen has launched QIAstat‑Dx Rise, a version of the QIAstat-Dx automated syndromic testing system. The FDA-cleared system is designed to meet the needs of hospitals and reference laboratories seeking highly automated syndromic testing with automated loading and unloading of cartridges, access to priority handling of urgent samples, and a minimum hands-on time. It delivers real-time PCR-based detection of multiple pathogens from a single sample and is able to run up to 160 tests per day across eight analytical modules, including 16 batch samples and two urgent slots per run. The Respiratory Panel Plus and Respiratory Panel Mini are already available on the system, and the company plans to add its family of gastrointestinal panels to the system.
Webinars and Sponsored Roundtables — Register Now
Wednesday, July 29, 2026, 1:00-2:00 PM ET
Learn about digital pathology technology that is future-ready, yet practical for today’s
laboratory needs.
Webinar presenters Scott Hammond, Senior Systems Consultant, Digital Pathology Division, Wexner Medical Center, Department of Pathology, and Ursula Hofer, Imaging Technologist, Pathology Digital Imaging Lab, Wexner Medical Center, Department of Pathology, and Sandra Banky, PA(ASCP), Director of Operations, Wexner Medical Center, Department of Pathology.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY